The best small-cap ETFs post above-average returns while taking on lower-than-expected risk. Learn about these six top picks ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...

Vanguard Small-Cap ETF VB offers a well-diversified, low-turnover portfolio that is representative of the US small-cap market. These features, coupled with a minuscule fee, make it one of the best ...

The small‑cap tech sector — broadly companies often defined in the U.S. as those with market capitalizations under roughly $200 million to $2 billion — currently occupies a precarious yet potentially ...

A small-cap value fund is a good choice for investors seeking diversification across sectors and companies, and focusing on gaining exposure to stocks trading at a discount. Investors with a high-risk ...

The US Federal Reserve lowered its benchmark interest rate by 25 basis points on Wednesday – marking its first rate cut since December 2024. Ahead of the announcement, the CME FedWatch Tool ...

Small-cap and mid-cap stocks have sold off recently and now appear cheap relative to large-cap AI growth names. The iShares Core S&P Small-Cap ETF (IJR) offers a 1.9% dividend yield and focuses on ...

In this article, we will look at the 11 Small Cap EV Stocks to Buy According to Analysts. On September 12, Reuters reported that Rho Motion data suggests that the global sales of fully electric and ...

Small caps are poised to finish 2025 with a fifth consecutive year of trailing large caps, yet Bank of America says conditions are aligning for a long-awaited reversal in 2026. According to Bank of ...

The Avantis US Small Cap Value ETF is an actively managed small-cap value fund with a 0.25% expense ratio and over $17 billion in assets. It's noted for delivering above-average returns every year ...

IJS consistently underperforms similar passively managed small-cap value ETFs, notably VBR and FISVX, over the short and long term. The fund's risk-adjusted returns are poor, with a negative Sharpe ...